Funder

Number of items: 25.
A
  • Feldman, William B., Tu, S. Sean, Alhiary, Rasha, Kesselheim, Aaron S., Wouters, Olivier J. (2023). Manufacturer revenue on inhalers after expiration of primary patents, 2000-2021. JAMA, 329(1), 87 - 89. https://doi.org/10.1001/jama.2022.19691 picture_as_pdf
  • Papanicolas, Irene, Figueroa, Jose F., Schoenfeld, Andrew J., Riley, Kristen, Abiona, Olukorede, Arvin, Mina, Atsma, Femke, Bernal‐delgado, Enrique, Bowden, Nicholas & Blankart, Carl Rudolf et al (2021). Differences in health care spending and utilization among older frail adults in high‐income countries: ICCONIC hip fracture persona. Health Services Research, 56(S3), 1335 - 1346. https://doi.org/10.1111/1475-6773.13739 picture_as_pdf
  • Papanicolas, Irene, Riley, Kristen, Abiona, Olukorede, Arvin, Mina, Atsma, Femke, Bernal‐delgado, Enrique, Bowden, Nicholas, Blankart, Carl Rudolf, Deeny, Sarah & Estupiñán‐romero, Francisco et al (2021). Differences in health outcomes for high‐need high‐cost patients across high-income countries. Health Services Research, 56(S3), 1347 - 1357. https://doi.org/10.1111/1475-6773.13735 picture_as_pdf
  • Figueroa, Jose F., Papanicolas, Irene, Riley, Kristen, Abiona, Olukorede, Arvin, Mina, Atsma, Femke, Bernal‐delgado, Enrique, Bowden, Nicholas, Blankart, Carl Rudolf & Deeny, Sarah et al (2021). International comparison of health spending and utilization among people with complex multimorbidity. Health Services Research, 56(S3), 1317 - 1334. https://doi.org/10.1111/1475-6773.13708 picture_as_pdf
  • Blankart, Carl Rudolf, Gool, Kees, Papanicolas, Irene, Bernal‐delgado, Enrique, Bowden, Nicholas, Estupiñán‐romero, Francisco, Gauld, Robin, Knight, Hannah, Abiona, Olukorede & Riley, Kristen et al (2021). International comparison of spending and utilization at the end of life for hip fracture patients. Health Services Research, 56(S3), 1370 - 1382. https://doi.org/10.1111/1475-6773.13734 picture_as_pdf
  • Or, Zeynep, Shatrov, Kosta, Penneau, Anne, Wodchis, Walter, Abiona, Olukorede, Blankart, Carl Rudolf, Bowden, Nicholas, Bernal‐delgado, Enrique, Knight, Hannah & Lorenzoni, Luca et al (2021). Within and across country variations in treatment of patients with heart failure and diabetes. Health Services Research, 56(S3), 1358 - 1369. https://doi.org/10.1111/1475-6773.13854 picture_as_pdf
  • Wodchis, Walter P., Or, Zeynep, Blankart, Carl Rudolf, Atsma, Femke, Janlov, Nils, Bai, Yu Qing, Penneau, Anne, Arvin, Mina, Knight, Hannah & Riley, Kristen et al (2021). An international comparison of long‐term care trajectories and spending following hip fracture. Health Services Research, 56(S3), 1383 - 1393. https://doi.org/10.1111/1475-6773.13864 picture_as_pdf
  • Figueroa, Jose F., Horneffer, Kathryn E., Riley, Kristen, Abiona, Olukorede, Arvin, Mina, Atsma, Femke, Bernal-Delgado, Enrique, Blankart, Carl Rudolf, Bowden, Nicholas & Deeny, Sarah et al (2021). A methodology for identifying high-need, high-cost patient personas for international comparisons. Health Services Research, 56(S3), 1302 - 1316. https://doi.org/10.1111/1475-6773.13890 picture_as_pdf
    • B
  • Teng, Theodore W., Tu, S. Sean, Mooney, Helen, Bendicksen, Liam, Gabriele, Sarah M.E., Wouters, Olivier J., Feldman, William B. (2026). Tertiary patents on drugs approved by the FDA. JAMA Health Forum, 7(1), e255909. https://doi.org/10.1001/jamahealthforum.2025.5909
  • Lorenzoni, Luca, Marino, Alberto, Or, Zeynep, Blankart, Carl Rudolf, Shatrov, Kosta, Wodchis, Walter, Janlov, Nils, Figueroa, Jose F., Bowden, Nicholas & Bernal-Delgado, Enrique et al (2023). Why the US spends more treating high-need high-cost patients: a comparative study of pricing and utilization of care in six high-income countries. Health Policy, 128, 55 - 61. https://doi.org/10.1016/j.healthpol.2022.12.004 picture_as_pdf
    • C
  • Li, Kevin H., Cousin, Emma M., Gabriel, Nico, Sullivan, Sean D. (2026). Integrating price benchmarks and comparative clinical effectiveness to predict initial price offers for Medicare Drug Price Negotiation (Initial Price Applicability Year 2027). Value in Health, 29(1), 64 - 72. https://doi.org/10.1016/j.jval.2025.09.3054
  • Sullivan, Sean D., Cousin, Emma M., Li, Kevin H., Gabriel, Nico, Martin, Kristi (2025). Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation. Journal of Managed Care & Specialty Pharmacy, 31(10), 968 - 981. https://doi.org/10.18553/jmcp.2025.25199
  • Vogel, Matthew, Feldman, William B., Cowan, Zander, Rome, Benjamin N., Chandra, Amitabh, Kesselheim, Aaron S., Wouters, Olivier J. (2025). Revenue differences between top-selling small-molecule drugs and biologics in medicare. JAMA Health Forum, 6(10). https://doi.org/10.1001/jamahealthforum.2025.4720
  • Wouters, Olivier J., Sullivan, Sean D., Cousin, Emma M., Gabriel, Nico, Papanicolas, Irene, Hernandez, Inmaculada (2024). Drug prices negotiated by medicare vs US net prices and prices in other countries. JAMA, 333(1), 85-87. https://doi.org/10.1001/jama.2024.22582 picture_as_pdf
  • Sullivan, Sean D., Wouters, Olivier J., Cousin, Emma M., Kirihennedige, Ayuri S., Hernandez, Inmaculada (2024). Integrating price benchmarks and comparative clinical effectiveness to inform the medicare drug price negotiation program. Value in Health, 27(10), 1348 - 1357. https://doi.org/10.1016/j.jval.2024.08.001 picture_as_pdf
  • Hernandez, Inmaculada, Cousin, Emma M., Wouters, Olivier J., Gabriel, Nico, Cameron, Teresa, Sullivan, Sean D. (2024). Price benchmarks of drugs selected for medicare price negotiation and their therapeutic alternatives. Journal of Managed Care & Specialty Pharmacy, 30(8), 762 - 772. https://doi.org/10.18553/jmcp.2024.24153 picture_as_pdf
  • Hernandez, Inmaculada, Cousin, Emma, Wouters, Olivier J., Gabriel, Nico, Cameron, Teresa, Sullivan, Sean D. (2024). Medicare drug price negotiation: the complexities of selecting therapeutic alternatives for estimating comparative effectiveness. Journal of Managed Care & Specialty Pharmacy, 30(3), 218 - 225. https://doi.org/10.18553/jmcp.2023.23277 picture_as_pdf
  • Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S., Gyawali, Bishal, Mossialos, Elias (2021). Assessment of coverage in England of cancer drugs qualifying for US food and drug administration accelerated approval. JAMA Internal Medicine, 181(4), 490 - 498. https://doi.org/10.1001/jamainternmed.2020.8441 picture_as_pdf
  • Cooper, Zack, Craig, Stuart, Gaynor, Martin, Harish, Nir J, Krumholz, Harlan M, Van Reenen, John (2019). Hospital prices grew substantially faster than physician prices for hospital-based care in 2007-14. Health Affairs, 38(2), 184 - 189. https://doi.org/10.1377/hlthaff.2018.05424
    • D
  • Wouters, Olivier J., Denolle, Cyprien, Wei, Jinru, Papanicolas, Irene (2025). Prices and affordability of essential medicines in 72 low-, middle-, and high-income markets. JAMA Health Forum, 6(8). https://doi.org/10.1001/jamahealthforum.2025.2043 picture_as_pdf
    • F
  • Papanicolas, Irene, Figueroa, Jose F. (2021). International comparison of patient care trajectories: insights from the ICCONIC project. Health Services Research, 56(S3), 1295 - 1298. https://doi.org/10.1111/1475-6773.13887 picture_as_pdf
    • H
  • Papanicolas, Irene, Wouters, Olivier J., Sawaya, Tania, Han, Jihye, Wei, Jinru, Naci, Huseyin (2026). Review times for new drugs and submission delays among the FDA and 4 international regulators, 2014–22. Health Affairs, 45(2), 184-192. https://doi.org/10.1377/hlthaff.2025.00595
    • L
  • Naci, Huseyin, Murphy, Peter, Woods, Beth, Lomas, James, Wei, Jinru, Papanicolas, Irene (2025). Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis. The Lancet, 405(10472), 50 - 60. https://doi.org/10.1016/S0140-6736(24)02352-3 picture_as_pdf
    • M
  • Wenzl, Martin, Mossialos, Elias (2018). Prices for cardiac implant devices may be up to six times higher in the US than in some European countries. Health Affairs, 37(10), 1570-1577. https://doi.org/10.1377/hlthaff.2017.1367
    • N
  • Wouters, Olivier J., Naci, Huseyin, Papanicolas, Irene (2024). Availability and coverage of new drugs in 6 high-income countries with health technology assessment bodies. Journal of American Medical Association: Internal Medicine, 184(3), 328 - 330. https://doi.org/10.1001/jamainternmed.2023.7726 picture_as_pdf